Literature DB >> 2983658

Primary structure of the A chain of human complement-classical-pathway enzyme C1r. N-terminal sequences and alignment of autolytic fragments and CNBr-cleavage peptides.

J Gagnon, G J Arlaud.   

Abstract

Activated human complement-classical-pathway enzyme C1r has previously been shown to undergo autolytic cleavages occurring in the A chain [Arlaud, Villiers, Chesne & Colomb (1980) Biochim. Biophys. Acta 616, 116-129]. Chemical analysis of the autolytic products confirms that the A chain undergoes two major cleavages, generating three fragments, which have now been isolated and characterized. The N-terminal alpha fragment (approx. 210 residues long) has a blocked N-terminus, as does the whole A chain, whereas N-terminal sequences of fragments beta and gamma (approx. 66 and 176 residues long respectively) do not, and their N-terminal sequences were determined. Fragments alpha, beta and gamma, which are not interconnected by disulphide bridges, are located in this order within C1r A chain. Fragment gamma is disulphide-linked to the B chain of C1r, which is C-terminal in the single polypeptide chain of precursor C1r. CNBr cleavage of C1r A chain yields seven major peptides, CN1b, CN4a, CN2a, CN1a, CN3, CN4b and CN2b, which were positioned in that order, on the basis of N-terminal sequences of the methionine-containing peptides generated from tryptic cleavage of the succinylated (3-carboxypropionylated) C1r A chain. About 60% of the sequence of C1r A chain (440-460 residues long) was determined, including the complete sequence of the C-terminal 95 residues. This region shows homology with the corresponding parts of plasminogen and chymotrypsinogen and, more surprisingly, with the alpha 1 chain of human haptoglobin 1-1, a serine proteinase homologue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983658      PMCID: PMC1144561          DOI: 10.1042/bj2250135

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.

Authors:  D M Johnson; J Gagnon; K B Reid
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

Review 2.  The first component of human complement--C1.

Authors:  R B Sim
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Isolation, characterization and N-terminal sequences of the CNBr-cleavage peptides from human complement Factor B. Localization of a free thiol group and a sequence defining the site cleaved by factor D.

Authors:  D L Christie; J Gagnon
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

Review 4.  The proteolytic activation systems of complement.

Authors:  K B Reid; R R Porter
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

5.  Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.

Authors:  G J Arlaud; C L Villiers; S Chesne; M G Colomb
Journal:  Biochim Biophys Acta       Date:  1980-11-06

6.  Covalent modification of an adenosine 3':5'-monophosphate binding site of the regulatory subunit of cAMP-dependent protein kinase II with 8-azidoadenosine 3':5'-monophosphate. Identification of a single modified tyrosine residue.

Authors:  A R Kerlavage; S S Taylor
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

7.  Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.

Authors:  R J Ziccardi
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.

Authors:  G J Arlaud; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

9.  Complete amino acid sequence of the catalytic chain of human complement subcomponent C1-r.

Authors:  G J Arlaud; J Gagnon
Journal:  Biochemistry       Date:  1983-04-12       Impact factor: 3.162

10.  Covalent structure of human haptoglobin: a serine protease homolog.

Authors:  A Kurosky; D R Barnett; T H Lee; B Touchstone; R E Hay; M S Arnott; B H Bowman; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  8 in total

1.  Characterization of a cDNA encoding RP43, a CUB-domain-containing protein from the tube of Riftia pachyptila (Vestimentifera), and distribution of its transcript.

Authors:  L Chamoy; M Nicolaï; B Quennedey; F Gaill; J Delachambre
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

2.  Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.

Authors:  M B Lacroix; C A Aude; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

3.  Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r.

Authors:  A Journet; M Tosi
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

4.  Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r.

Authors:  G J Arlaud; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

Review 6.  Hemodialysis-Related Complement and Contact Pathway Activation and Cardiovascular Risk: A Narrative Review.

Authors:  Sarah C Skinner; Vimal K Derebail; Caroline J Poulton; Donna C Bunch; Prabir Roy-Chaudhury; Nigel S Key
Journal:  Kidney Med       Date:  2021-06-09

7.  Human genes for complement components C1r and C1s in a close tail-to-tail arrangement.

Authors:  H Kusumoto; S Hirosawa; J P Salier; F S Hagen; K Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes.

Authors:  Jialei Xie; Hui Zhi; Ryan J Garrigues; Andrew Keightley; Brandon L Garcia; Jon T Skare
Journal:  PLoS Pathog       Date:  2019-03-21       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.